tiprankstipranks
Trending News
More News >
Tauns Laboratories, Inc. (JP:197A)
:197A
Japanese Market
Advertisement

Tauns Laboratories, Inc. (197A) Financial Statements

Compare
0 Followers

Tauns Laboratories, Inc. Financial Overview

Tauns Laboratories, Inc.'s market cap is currently ¥57.85B. The company's EPS TTM is ¥-3.46; its P/E ratio is 9.04; and it has a dividend yield of 3.14%. Tauns Laboratories, Inc. is scheduled to report earnings on August 13, 2025, and the estimated EPS forecast is ¥―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22
Income Statement
Total Revenue¥ 18.63B¥ 18.43B¥ 15.67B¥ 17.46B
Gross Profit¥ 12.33B¥ 12.50B¥ 8.79B¥ 14.29B
Operating Income¥ 8.27B¥ 8.03B¥ 4.97B¥ 11.19B
EBITDA¥ 9.02B¥ 8.65B¥ 5.32B¥ 8.55B
Net Income¥ 6.32B¥ 5.77B¥ 3.03B¥ 4.48B
Balance Sheet
Cash & Short-Term Investments¥ 9.27B¥ 9.42B¥ 1.24B¥ 6.35B
Total Assets¥ 36.52B¥ 29.26B¥ 18.81B¥ 20.88B
Total Debt¥ 14.42B¥ 9.54B¥ 6.47B¥ 4.90B
Net Debt¥ 5.16B¥ 114.11M¥ 5.22B¥ -1.45B
Total Liabilities¥ 19.10B¥ 15.59B¥ 10.32B¥ 13.52B
Stockholders' Equity¥ 17.42B¥ 13.67B¥ 8.49B¥ 7.36B
Cash Flow
Free Cash Flow¥ 2.14B¥ 5.97B¥ -4.32B¥ 8.39B
Operating Cash Flow¥ 6.82B¥ 9.94B¥ -3.16B¥ 10.69B
Investing Cash Flow¥ -9.26B¥ -4.11B¥ -1.62B¥ -2.68B
Financing Cash Flow¥ 2.28B¥ 2.36B¥ -330.20M¥ -3.66B
Currency in JPY

Tauns Laboratories, Inc. Earnings and Revenue History

Tauns Laboratories, Inc. Debt to Assets

Tauns Laboratories, Inc. Cash Flow

Tauns Laboratories, Inc. Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis